Esperion Therapeutics, Inc. — Director's Dealing 2021

Nov 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Esperion Therapeutics, Inc. (ESPR)
CIK: 0001434868
Period of Report: 2021-10-28

Reporting Person: Fischer Seth H. Z. (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$8.85	2031-10-28	Common Stock (40000.0)	40000	Direct

Footnotes

F1: The awards vest over a three (3) year period in equal annual installments, the first of which will be October 28, 2022.